Seeing Is Believing
CABA is currently covered by 5 analysts with an average price target of $15.63. This is a potential upside of $11.07 (437.11%) from yesterday's end of day stock price of $2.91.
Cabaletta Bio's activity chart (see below) currently has 50 price targets and 76 ratings on display. The stock rating distribution of CABA is 77.78% BUY and 22.22% HOLD.
Analysts average stock forecasts to be materialized ratio is 33.37% with an average time for these price targets to be met of 300.09 days.
Highest price target for CABA is $30, Lowest price target is $3, average price target is $15.63.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 13-Aug-2026. First documented stock forecast 18-Nov-2019.
Currently out of the existing stock ratings of CABA, 7 are a BUY (77.78%), 2 are a HOLD (22.22%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Mar-2025
$3
$0.25 (9.09%)
$4
Buy Since 19-Nov-2019
$30
$26.96 (886.84%)
$15
Buy Since 30-Aug-2022
$13
$9.96 (327.63%)
Buy Since 18-Jul-2023
$16
$12.96 (426.32%)
$15
What is CABA (Cabaletta Bio) average time for price targets to be met?
Which analyst has the current highest performing score on CABA (Cabaletta Bio) with a proven track record?
Which analyst has the most public recommendations on CABA (Cabaletta Bio)?
Which analyst is the currently most bullish on CABA (Cabaletta Bio)?
Which analyst is the currently most reserved on CABA (Cabaletta Bio)?